In vitro cytotoxicity and teratogenicity of norethisterone and levonorgestrel released from hollow nylon monofilaments

被引:5
作者
Ostad, SN
Malhi, JS
Gard, PR
机构
[1] Univ Brighton, Dept Pharm, Brighton BN2 4GJ, E Sussex, England
[2] Liverpool John Moores Univ, Sch Pharm & Chem, Liverpool L3 3AF, Merseyside, England
关键词
norethisterone; levonorgestrel; hormone replacement therapy; intrauterine device; drug delivery;
D O I
10.1016/S0168-3659(97)00132-6
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Direct delivery of progestogens to the uterus may be of use in the treatment of dysfunctional uterine bleeding and the sequelae of the menopause as it has the potential to overcome the problems of systemic administration. This study characterised the release of norethisterone and levonorgestrel into an aqueous medium from hollow nylon fibres with dimensions suitable for easy insertion through the post-menopausal cervix. Cell culture techniques were used to assess potential cytotoxic and teratogenic effects. The results demonstrated that the hollow fibres released norethisterone and levonorgestrel at mean rates of 0.5 and 0.6 mu g/day over 14 days, respectively. There were indications, however, that both steroids were toxic to endometrial cells at concentrations of approximately 5 mu g/ml, and bath drugs showed signs of potential teratogenicity at 10 mu g/ml. Delivery of the same doses of norethisterone using the hollow fibres reduced the effects on the endometrial and fetal cells. Delivery of levonorgestrel from the hollow fibres had no effect on the endometrial cell toxicity but potentiated the effects on the fetal cells. These results suggest that the hollow nylon fibres may be of use for the delivery of norethisterone to the uterus but that they are inappropriate for the delivery of levonorgestrel. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:179 / 186
页数:8
相关论文
共 23 条
[1]  
EDGREN RA, 1996, RECENT PROG HORM RES, V22, P305
[2]   DIFFERENTIATION OF RAT EMBRYO CELLS IN CULTURE - RESPONSE FOLLOWING ACUTE MATERNAL EXPOSURE TO TERATOGENS AND NON-TERATOGENS [J].
FLINT, OP ;
ORTON, TC ;
FERGUSON, RA .
JOURNAL OF APPLIED TOXICOLOGY, 1984, 4 (02) :109-116
[3]   AN INVITRO ASSAY FOR TERATOGENS WITH CULTURES OF RAT EMBRYO MIDBRAIN AND LIMB BUD CELLS [J].
FLINT, OP ;
ORTON, TC .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1984, 76 (02) :383-395
[4]  
GAMBRELL RD, 1991, AM J OBSTET GYNECOL, V165, P307
[5]   HAZARDS OF NORETHINDRONE THERAPY DURING PREGNANCY [J].
JACOBSON, BD .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1962, 84 (07) :962-&
[6]   ORAL-CONTRACEPTIVES AND CONGENITAL LIMB-REDUCTION DEFECTS [J].
JANERICH, DT ;
PIPER, JM ;
GLEBATIS, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (14) :697-700
[7]   CHONDROGENESIS OF LIMB-BUD CELLS - IMPROVED CULTURE METHOD AND THE EFFECT OF THE POTENT TERATOGEN RETINOIC ACID [J].
KISTLER, A ;
MISLIN, M ;
GEHRIG, A .
XENOBIOTICA, 1985, 15 (8-9) :673-679
[8]  
Lewis MA, 1996, BRIT MED J, V312, P88
[9]   5 YEARS EXPERIENCE WITH LEVONORGESTREL-RELEASING IUDS [J].
LUUKKAINEN, T ;
ALLONEN, H ;
HAUKKAMAA, M ;
LAHTEENMAKI, P ;
NILSSON, CG ;
TOIVONEN, J .
CONTRACEPTION, 1986, 33 (02) :139-148
[10]   EFFECTS OF ESTRADIOL VALERATE PLUS 2 DIFFERENT PROGESTOGENS ON SERUM-LIPIDS DURING POSTMENOPAUSAL REPLACEMENT THERAPY [J].
MAKKONEN, M ;
SAARIKOSKI, S ;
PENTTILA, I .
MATURITAS, 1991, 14 (01) :43-48